167 related articles for article (PubMed ID: 32737364)
1. Roniciclib down-regulates stemness and inhibits cell growth by inducing nucleolar stress in neuroblastoma.
Ognibene M; Pezzolo A
Sci Rep; 2020 Jul; 10(1):12902. PubMed ID: 32737364
[TBL] [Abstract][Full Text] [Related]
2. A c-Myc-regulated stem cell-like signature in high-risk neuroblastoma: A systematic discovery (Target neuroblastoma ESC-like signature).
Yang XH; Tang F; Shin J; Cunningham JM
Sci Rep; 2017 Mar; 7(1):41. PubMed ID: 28246384
[TBL] [Abstract][Full Text] [Related]
3. MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells.
Schulte JH; Lindner S; Bohrer A; Maurer J; De Preter K; Lefever S; Heukamp L; Schulte S; Molenaar J; Versteeg R; Thor T; Künkele A; Vandesompele J; Speleman F; Schorle H; Eggert A; Schramm A
Oncogene; 2013 Feb; 32(8):1059-65. PubMed ID: 22484425
[TBL] [Abstract][Full Text] [Related]
4. G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.
Hsu DM; Agarwal S; Benham A; Coarfa C; Trahan DN; Chen Z; Stowers PN; Courtney AN; Lakoma A; Barbieri E; Metelitsa LS; Gunaratne P; Kim ES; Shohet JM
Cancer Res; 2013 Jul; 73(13):4134-46. PubMed ID: 23687340
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of the Lamin A/C in neuroblastoma triggers the expansion of tumor initiating cells.
Nardella M; Guglielmi L; Musa C; Iannetti I; Maresca G; Amendola D; Porru M; Carico E; Sessa G; Camerlingo R; Dominici C; Megiorni F; Milan M; Bearzi C; Rizzi R; Pirozzi G; Leonetti C; Bucci B; Mercanti D; Felsani A; D'Agnano I
Oncotarget; 2015 Oct; 6(32):32821-40. PubMed ID: 26439802
[TBL] [Abstract][Full Text] [Related]
6. Potent effects of roniciclib alone and with sorafenib against well-differentiated thyroid cancer.
Lin SF; Lin JD; Hsueh C; Chou TC; Wong RJ
Endocr Relat Cancer; 2018 Oct; 25(10):853-864. PubMed ID: 29895526
[TBL] [Abstract][Full Text] [Related]
7. The cultivation and identification of tumor stem cells from neuroblastoma derived tumor spheres.
Liu QX; Tang JY; Cai JY; Yin MZ; Li BS
Chin J Cancer; 2010 Dec; 29(12):1012-7. PubMed ID: 21114922
[TBL] [Abstract][Full Text] [Related]
8. Β-carotene inhibits neuroblastoma tumorigenesis by regulating cell differentiation and cancer cell stemness.
Lim JY; Kim YS; Kim KM; Min SJ; Kim Y
Biochem Biophys Res Commun; 2014 Aug; 450(4):1475-80. PubMed ID: 25019987
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein 70 modulates neural progenitor cells dynamics in human neuroblastoma SH-SY5Y cells exposed to high glucose content.
Salimi L; Rahbarghazi R; Jafarian V; Biray Avci Ç; Goker Bagca B; Pinar Ozates N; Khaksar M; Nourazarian A
J Cell Biochem; 2018 Aug; 119(8):6482-6491. PubMed ID: 29345335
[TBL] [Abstract][Full Text] [Related]
10. NLRR1 enhances EGF-mediated MYCN induction in neuroblastoma and accelerates tumor growth in vivo.
Hossain S; Takatori A; Nakamura Y; Suenaga Y; Kamijo T; Nakagawara A
Cancer Res; 2012 Sep; 72(17):4587-96. PubMed ID: 22815527
[TBL] [Abstract][Full Text] [Related]
11. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
[TBL] [Abstract][Full Text] [Related]
12. Analysis of stemness gene expression and CD133 abnormal methylation in neuroblastoma cell lines.
Schiapparelli P; Enguita-Germán M; Balbuena J; Rey JA; Lázcoz P; Castresana JS
Oncol Rep; 2010 Nov; 24(5):1355-62. PubMed ID: 20878131
[TBL] [Abstract][Full Text] [Related]
13. Distinct biological characterization of the CD44 and CD90 phenotypes of cancer stem cells in gastric cancer cell lines.
Shu X; Liu H; Pan Y; Sun L; Yu L; Sun L; Yang Z; Ran Y
Mol Cell Biochem; 2019 Sep; 459(1-2):35-47. PubMed ID: 31073886
[TBL] [Abstract][Full Text] [Related]
14. Preliminary analysis of stem cell-like cells in human neuroblastoma.
Xing LL; Sha YL; Wu YM; Hu JM; Zhang M; Lv F
World J Pediatr; 2015 Feb; 11(1):54-60. PubMed ID: 25431041
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional co-activator TAZ sustains proliferation and tumorigenicity of neuroblastoma by targeting CTGF and PDGF-β.
Wang M; Liu Y; Zou J; Yang R; Xuan F; Wang Y; Gao N; Cui H
Oncotarget; 2015 Apr; 6(11):9517-30. PubMed ID: 25940705
[TBL] [Abstract][Full Text] [Related]
16. CFC1 is a cancer stemness-regulating factor in neuroblastoma.
Chikaraishi K; Takenobu H; Sugino RP; Mukae K; Akter J; Haruta M; Kurosumi M; Endo TA; Koseki H; Shimojo N; Ohira M; Kamijo T
Oncotarget; 2017 Jul; 8(28):45046-45059. PubMed ID: 28620148
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of BORIS/CTCFL efficiently regulates cancer stemness and metastasis in MYCN amplified neuroblastoma cell line by modulating Wnt/β-catenin signaling pathway.
Garikapati KR; Patel N; Makani VKK; Cilamkoti P; Bhadra U; Bhadra MP
Biochem Biophys Res Commun; 2017 Feb; 484(1):93-99. PubMed ID: 28104398
[TBL] [Abstract][Full Text] [Related]
18. miR-103/107 prolong Wnt/β-catenin signaling and colorectal cancer stemness by targeting Axin2.
Chen HY; Lang YD; Lin HN; Liu YR; Liao CC; Nana AW; Yen Y; Chen RH
Sci Rep; 2019 Jul; 9(1):9687. PubMed ID: 31273221
[TBL] [Abstract][Full Text] [Related]
19. Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas.
Cantilena S; Pastorino F; Pezzolo A; Chayka O; Pistoia V; Ponzoni M; Sala A
Oncotarget; 2011 Dec; 2(12):976-83. PubMed ID: 22249030
[TBL] [Abstract][Full Text] [Related]
20. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.
Chau WK; Ip CK; Mak AS; Lai HC; Wong AS
Oncogene; 2013 May; 32(22):2767-81. PubMed ID: 22797058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
